<DOC>
	<DOC>NCT00743470</DOC>
	<brief_summary>The purpose of this study is to study the safety, tolerability and pharmacokinetics of rifabutin dosing with lopinavir/ritonavir tablets in healthy volunteers.</brief_summary>
	<brief_title>A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Rifabutin</mesh_term>
	<criteria>Adult Male or Female 1855 yrs. Subject has provided written consent. Subject is in general good health. If female, subject is postmenopausal. If female, subject is not pregnant and is not breastfeeding. Subject must use birth control methods or be surgically sterile. Subject is HAVIgM, HBsAg or HIV Ab positive. Positive screen for drugs of abuse, alcohol, or smoking. Cannot be on any medication, including over the counter drugs. Cannot have previous history of alcohol or drug abuse. Cannot have history of any major diseases or disorders.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>HIV co-infected with tuberculosis</keyword>
</DOC>